NCT03539263

Brief Summary

Recent demonstration that probiotics administration has positive effects on depressive feelings in healthy populations suggests its possible role as an adjuvant therapy for depression in clinical populations and as a non-invasive strategy to prevent depressive feelings in healthy individuals. The present study extends current knowledge on the beneficial effects of probiotics on psychological well-being, as measured by changes in mood (e.g., depression, anxiety, cognitive reactivity to sad mood), personality dimensions, and quality of sleep, which have been considered as related to mood. For this double-blind, placebo-controlled study healthy volunteers pseudo-randomly assigned to an experimental or control group assumed a daily dose of probiotic or placebo, respectively, for 6 weeks. Mood, personality dimensions, and sleep quality were assessed four times (before the beginning of the study, at 3 and 6 weeks, and at 3 weeks of washout).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 20, 2016

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2017

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 6, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 29, 2018

Completed
Last Updated

May 29, 2018

Status Verified

May 1, 2018

Enrollment Period

6 months

First QC Date

April 6, 2018

Last Update Submit

May 25, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in the psychological profile

    The primary outcome is the difference in the scores at the Leiden Index of Depression Sensitivity-Revised test (LEIDS-R) standardized questionnaire between the experimental and control groups. The Leiden Index of Depression Sensitivity-Revised test, LEIDS-R, is a self-report questionnaire that tests cognitive reactivity to sad mood, which is an index of cognitive vulnerability to depression.

    four evaluation sessions at intervals of three weeks of probiotic intervention

Secondary Outcomes (8)

  • Evaluation of mood - State Trait Anxiety Inventory (STAI) standardized questionnarie.

    four evaluation sessions at intervals of three weeks of probiotic intervention

  • Evaluation of mood - Beck Depression Inventory (BDI-2) standardized questionnarie.

    four evaluation sessions at intervals of three weeks of probiotic intervention

  • Evaluation of mood - Profile od Mood State (POMS) standardized questionnarie.

    four evaluation sessions at intervals of three weeks of probiotic intervention

  • Evaluation of the quality of sleep.

    four evaluation sessions at intervals of three weeks of probiotic intervention

  • Evaluation of personality - Temperament and Character Inventory (TCI) standardized questionnarie.

    four evaluation sessions at intervals of three weeks of probiotic intervention

  • +3 more secondary outcomes

Study Arms (2)

Group 1

EXPERIMENTAL

the subjects are treated with probiotics: Bifihappy

Dietary Supplement: Bifihappy

Group 2

PLACEBO COMPARATOR

the subjects are treated with a placebo

Other: Placebo

Interventions

BifihappyDIETARY_SUPPLEMENT

During the six weeks of treatment, the experimental group will take daily doses of 2,5 g with a concentration of 4x109 CFU/sachet of a mixture of lyophilised probiotic strains of the following species: * Lactobacillus fermentum * Lactobacillus rhamnosus * Lactobacillus plantarum * Bifidobacterium longum

Group 1
PlaceboOTHER

During the six weeks of treatment, the experimental group will take daily doses of 2,5 g of maltodextrin

Group 2

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male and Famale subjects.
  • Aged between 18 and 35.
  • Already owing a smartphone with Android or iOS system.

You may not qualify if:

  • Drug taking, smoking, coeliac disease, lactose intolerance.
  • Disorders such as IBS (Irritable Bowel Syndrome), IBD (Irritable Bowel Disease), UC (Ulcerative Colitis) and other serious diseases, e.g. MS (Multiple Sclerosis) and diabetes (type 1/type 2).
  • Oral intake of antibiotics and other medicines on a continuative basis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Verona

Verona, 37131, Italy

Location

Related Publications (45)

  • Barrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C. gamma-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. 2012 Aug;113(2):411-7. doi: 10.1111/j.1365-2672.2012.05344.x. Epub 2012 Jun 15.

    PMID: 22612585BACKGROUND
  • Beck A, Steer R, Brown G (1996). Manual for Beck Depression Inventory II (BDI-II). San Antonio, TX: Psychology Corporation

    BACKGROUND
  • Block J, Kremen AM. IQ and ego-resiliency: conceptual and empirical connections and separateness. J Pers Soc Psychol. 1996 Feb;70(2):349-61. doi: 10.1037//0022-3514.70.2.349.

    PMID: 8636887BACKGROUND
  • Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16050-5. doi: 10.1073/pnas.1102999108. Epub 2011 Aug 29.

    PMID: 21876150BACKGROUND
  • Bravo JA, Julio-Pieper M, Forsythe P, Kunze W, Dinan TG, Bienenstock J, Cryan JF. Communication between gastrointestinal bacteria and the nervous system. Curr Opin Pharmacol. 2012 Dec;12(6):667-72. doi: 10.1016/j.coph.2012.09.010. Epub 2012 Oct 4.

    PMID: 23041079BACKGROUND
  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.

    PMID: 2748771BACKGROUND
  • Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD (1994). The Temperament and Character Inventory (TCI): A Guide to Its Development and Use (St. Louis, MO: Center for Psychobiology of Personality, Washington University).

    BACKGROUND
  • Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012 Oct;13(10):701-12. doi: 10.1038/nrn3346. Epub 2012 Sep 12.

    PMID: 22968153BACKGROUND
  • Curcio G, Tempesta D, Scarlata S, Marzano C, Moroni F, Rossini PM, Ferrara M, De Gennaro L. Validity of the Italian version of the Pittsburgh Sleep Quality Index (PSQI). Neurol Sci. 2013 Apr;34(4):511-9. doi: 10.1007/s10072-012-1085-y. Epub 2012 Apr 13.

    PMID: 22526760BACKGROUND
  • Davis MH (1980). A multidimensional approach to individual differences in empathy. JSAS Catalog of Selected Documents in Psychology, 10, 85

    BACKGROUND
  • Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008 Dec;43(2):164-74. doi: 10.1016/j.jpsychires.2008.03.009. Epub 2008 May 5.

    PMID: 18456279BACKGROUND
  • Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010 Nov 10;170(4):1179-88. doi: 10.1016/j.neuroscience.2010.08.005. Epub 2010 Aug 6.

    PMID: 20696216BACKGROUND
  • Farma T & Cortinovis I (2001). Un questionario sul "Locus of Control": suo utilizzo nel contesto italiano. Ricerca in Psicoterapia, 1

    BACKGROUND
  • Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013 May;36(5):305-12. doi: 10.1016/j.tins.2013.01.005. Epub 2013 Feb 4.

    PMID: 23384445BACKGROUND
  • Fraher MH, O'Toole PW, Quigley EM. Techniques used to characterize the gut microbiota: a guide for the clinician. Nat Rev Gastroenterol Hepatol. 2012 Mar 27;9(6):312-22. doi: 10.1038/nrgastro.2012.44.

    PMID: 22450307BACKGROUND
  • GIRVIN GT, STEVENSON JW. Cell free choline acetylase from Lactobacillus plantarum. Can J Biochem Physiol. 1954 Mar;32(2):131-46. No abstract available.

    PMID: 13141176BACKGROUND
  • Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and disease. Front Physiol. 2011 Dec 7;2:94. doi: 10.3389/fphys.2011.00094. eCollection 2011.

    PMID: 22162969BACKGROUND
  • Grossman MI. Neural and hormonal regulation of gastrointestinal function: an overview. Annu Rev Physiol. 1979;41:27-33. doi: 10.1146/annurev.ph.41.030179.000331. No abstract available.

    PMID: 35089BACKGROUND
  • Komatsuzaki N, Nakamura T, Kimura T, Shima J. Characterization of glutamate decarboxylase from a high gamma-aminobutyric acid (GABA)-producer, Lactobacillus paracasei. Biosci Biotechnol Biochem. 2008 Feb;72(2):278-85. doi: 10.1271/bbb.70163. Epub 2008 Feb 7.

    PMID: 18256502BACKGROUND
  • Kotov RI, Belmman SB, Watson DB (2004). Multidimensional Iowa Suggestibility Scale (MISS) Brief Manual. Stony Brook School of Medicine.

    BACKGROUND
  • Leone L, Pierro A e Mannetti L. (2002). Validità della versione italiana delle scale BIS/BAS di Carver e White (1994): Generalizzabilità della struttura e relazioni con costrutti affini. Giornale Italiano di Psicologia, 2: 413-434.

    BACKGROUND
  • Li W, Dowd SE, Scurlock B, Acosta-Martinez V, Lyte M. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav. 2009 Mar 23;96(4-5):557-67. doi: 10.1016/j.physbeh.2008.12.004. Epub 2008 Dec 24.

    PMID: 19135464BACKGROUND
  • Lombardo C (2008). Adattamento italiano della Multidimensional Perfectionism Scale (MPS). Psicoterapia cognitiva e comportamentale, 14(1):31-46

    BACKGROUND
  • Martinez RC, Cardarelli HR, Borst W, Albrecht S, Schols H, Gutierrez OP, Maathuis AJ, de Melo Franco BD, De Martinis EC, Zoetendal EG, Venema K, Saad SM, Smidt H. Effect of galactooligosaccharides and Bifidobacterium animalis Bb-12 on growth of Lactobacillus amylovorus DSM 16698, microbial community structure, and metabolite production in an in vitro colonic model set up with human or pig microbiota. FEMS Microbiol Ecol. 2013 Apr;84(1):110-23. doi: 10.1111/1574-6941.12041. Epub 2012 Dec 17.

    PMID: 23167835BACKGROUND
  • Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011 Jul 13;12(8):453-66. doi: 10.1038/nrn3071.

    PMID: 21750565BACKGROUND
  • Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K. Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci. 2014 Nov 12;34(46):15490-6. doi: 10.1523/JNEUROSCI.3299-14.2014.

    PMID: 25392516BACKGROUND
  • McNair DM, Lorr M, Droppleman LF (1964). Poms. Profile of Mood States. San Diego: Educational and Industrial Testing Service; ad. it. Firenze: Giunti O.S. Organizzazioni Speciali, 1991.

    BACKGROUND
  • Mitsou EK, Kirtzalidou E, Oikonomou I, Liosis G, Kyriacou A. Fecal microflora of Greek healthy neonates. Anaerobe. 2008 Apr;14(2):94-101. doi: 10.1016/j.anaerobe.2007.11.002. Epub 2007 Dec 3.

    PMID: 18207437BACKGROUND
  • Muyzer G, de Waal EC, Uitterlinden AG. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol. 1993 Mar;59(3):695-700. doi: 10.1128/aem.59.3.695-700.1993.

    PMID: 7683183BACKGROUND
  • Özogul F (2004). Production of biogenic amines by Morganella morganii, Klebsiella pneumoniae andHafnia alvei using a rapid HPLC method. Eur Food Res Technol. 219:465-469.

    BACKGROUND
  • Özogul F, Kuley E, Özogul Y, Özogul I (2012). The function of lactic acid bacteria on bio-genic amines production by food-borne pathogens in arginine decarboxylasebroth. Food Sci Technol Res 18:795- 804

    BACKGROUND
  • Pellegrini N, Salvatore S, Valtuena S, Bedogni G, Porrini M, Pala V, Del Rio D, Sieri S, Miglio C, Krogh V, Zavaroni I, Brighenti F. Development and validation of a food frequency questionnaire for the assessment of dietary total antioxidant capacity. J Nutr. 2007 Jan;137(1):93-8. doi: 10.1093/jn/137.1.93.

    PMID: 17182807BACKGROUND
  • Pisani P, Faggiano F, Krogh V, Palli D, Vineis P, Berrino F. Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol. 1997;26 Suppl 1:S152-60. doi: 10.1093/ije/26.suppl_1.s152.

    PMID: 9126543BACKGROUND
  • Rowatt, E (1948). The relation of pantothcnic acid to acetylcholine formation by a strain of Lactobacillus plantarum. J. Gen. Microbiol. 2. 1, 25-30

    BACKGROUND
  • Saha DC, Reimer RA. Long-term intake of a high prebiotic fiber diet but not high protein reduces metabolic risk after a high fat challenge and uniquely alters gut microbiota and hepatic gene expression. Nutr Res. 2014 Sep;34(9):789-96. doi: 10.1016/j.nutres.2014.08.004. Epub 2014 Aug 23.

    PMID: 25217504BACKGROUND
  • Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol. 1994 Dec;67(6):1063-78. doi: 10.1037//0022-3514.67.6.1063.

    PMID: 7815302BACKGROUND
  • Shishov VA, Kirovskaia TA, Kudrin VS, Oleskin AV. [Amine neuromediators, their precursors, and oxidation products in the culture of Escherichia coli K-12]. Prikl Biokhim Mikrobiol. 2009 Sep-Oct;45(5):550-4. Russian.

    PMID: 19845286BACKGROUND
  • Sica C., Magni C., Ghisi M., Altoè G., Sighinolfi C., CHiri L.R., Franceschini S. (2008). Cope Orientation to Problems Experienced - Nuova Versione Italiana (COPE-NVI): uno strumento per la misura degli stili di coping. Psicoterapia cognitiva e comportamentale,14 (1):27-53

    BACKGROUND
  • Snart J, Bibiloni R, Grayson T, Lay C, Zhang H, Allison GE, Laverdiere JK, Temelli F, Vasanthan T, Bell R, Tannock GW. Supplementation of the diet with high-viscosity beta-glucan results in enrichment for lactobacilli in the rat cecum. Appl Environ Microbiol. 2006 Mar;72(3):1925-31. doi: 10.1128/AEM.72.3.1925-1931.2006.

    PMID: 16517639BACKGROUND
  • Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA(1983). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press

    BACKGROUND
  • Steenbergen L, Sellaro R, van Hemert S, Bosch JA, Colzato LS. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun. 2015 Aug;48:258-64. doi: 10.1016/j.bbi.2015.04.003. Epub 2015 Apr 7.

    PMID: 25862297BACKGROUND
  • Tsavkelova EA, Botvinko IV, Kudrin VS, Oleskin AV. Detection of neurotransmitter amines in microorganisms with the use of high-performance liquid chromatography. Dokl Biochem. 2000 May-Jun;372(1-6):115-7. No abstract available.

    PMID: 10935181BACKGROUND
  • van der Does W, Williams JMG (2003). Leiden Index of Depression Sensitivity - Revised (LEIDS-R). Leiden University.

    BACKGROUND
  • Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, Brown D, Stares MD, Scott P, Bergerat A, Louis P, McIntosh F, Johnstone AM, Lobley GE, Parkhill J, Flint HJ. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011 Feb;5(2):220-30. doi: 10.1038/ismej.2010.118. Epub 2010 Aug 5.

    PMID: 20686513BACKGROUND
  • Yang J, Fox M, Cong Y, Chu H, Zheng X, Long Y, Fried M, Dai N. Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity. Aliment Pharmacol Ther. 2014 Feb;39(3):302-11. doi: 10.1111/apt.12582. Epub 2013 Dec 5.

    PMID: 24308871BACKGROUND

MeSH Terms

Conditions

DepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The trial design is parallel, with two groups (experimental group and control group) and four evaluation sessions at intervals of three weeks (T0wk = baseline, T3wk = intermediate, T6wk=final and T9wk = follow-up).
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2018

First Posted

May 29, 2018

Study Start

December 20, 2016

Primary Completion

June 15, 2017

Study Completion

June 15, 2017

Last Updated

May 29, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will share

Study Protocol

Shared Documents
STUDY PROTOCOL
Time Frame
from April 2018
Access Criteria
Plos One

Locations